IN2014DN10209A - - Google Patents

Info

Publication number
IN2014DN10209A
IN2014DN10209A IN10209DEN2014A IN2014DN10209A IN 2014DN10209 A IN2014DN10209 A IN 2014DN10209A IN 10209DEN2014 A IN10209DEN2014 A IN 10209DEN2014A IN 2014DN10209 A IN2014DN10209 A IN 2014DN10209A
Authority
IN
India
Prior art keywords
rivaroxaban
preparation
present
provides
processes
Prior art date
Application number
Other languages
English (en)
Inventor
Pankaj Kumar Singh
Mukesh Kumar Sharma
Chandra Has Khanduri
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN10209DEN2014 priority Critical patent/IN2014DN10209A/en
Publication of IN2014DN10209A publication Critical patent/IN2014DN10209A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
IN10209DEN2014 2012-05-24 2013-05-23 IN2014DN10209A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN10209DEN2014 IN2014DN10209A (es) 2012-05-24 2013-05-23

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1591DE2012 2012-05-24
IN10209DEN2014 IN2014DN10209A (es) 2012-05-24 2013-05-23
PCT/IB2013/054280 WO2013175431A1 (en) 2012-05-24 2013-05-23 Process for the preparation of rivaroxaban

Publications (1)

Publication Number Publication Date
IN2014DN10209A true IN2014DN10209A (es) 2015-08-07

Family

ID=54193702

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10209DEN2014 IN2014DN10209A (es) 2012-05-24 2013-05-23

Country Status (5)

Country Link
US (1) US20150133657A1 (es)
EP (1) EP2855465A1 (es)
IN (1) IN2014DN10209A (es)
SG (1) SG11201407518SA (es)
WO (1) WO2013175431A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016150937A1 (en) 2015-03-25 2016-09-29 Lonza Ltd Method for preparation of thiophenecarbonyl chlorides
WO2016199027A1 (en) * 2015-06-08 2016-12-15 Mehta Api Pvt. Ltd. An improved process for preparation of rivaroxaban
TW201720807A (zh) * 2015-11-04 2017-06-16 隆薩有限公司 用草醯氯製備噻吩-2-羰醯氯的方法
WO2023088229A1 (zh) * 2021-11-17 2023-05-25 浙江华海药业股份有限公司 一种利伐沙班的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2205822C2 (ru) 1997-11-07 2003-06-10 Фармация Энд Апджон Компани Способы получения (s)-оксазолидинонов, (s)-вторичный спирт, соединение, способ получения спирта
DE19962924A1 (de) * 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10322469A1 (de) 2003-05-19 2004-12-16 Bayer Healthcare Ag Heterocyclische Verbindungen
DE102007032347A1 (de) 2007-07-11 2009-01-15 Bayer Healthcare Ag Aminoacyl-Prodrugs
EP2354128A1 (en) * 2010-02-10 2011-08-10 Sandoz Ag Method for the preparation of rivaroxaban

Also Published As

Publication number Publication date
WO2013175431A1 (en) 2013-11-28
US20150133657A1 (en) 2015-05-14
SG11201407518SA (en) 2014-12-30
EP2855465A1 (en) 2015-04-08

Similar Documents

Publication Publication Date Title
PH12016501192B1 (en) Tetrahydropyridopyrazines modulators of gpr6
UY34780A (es) Vectores virales para el tratamiento de distrofia retiniana
IN2015DN00127A (es)
SG10201805410XA (en) Therapeutic agent or prophylactic agent for dementia
PH12015501059A1 (en) Anti-hemagglutinin antibodies and methods of use
MX370649B (es) Proceso para la preparacion de teneligliptina.
IN2014DN09450A (es)
IN2012MU03723A (es)
JO3755B1 (ar) تركيبات تستوستيرون
IN2013MU00848A (es)
EA026371B8 (ru) Индолкарбонитрилы в качестве модуляторов рецептора андрогенов
GEP201706626B (en) Synthesis of (s)-nifuratel
IN2014CN00312A (es)
IN2014DN10209A (es)
IN2013MU01113A (es)
IN2014CH00304A (es)
GEP201706708B (en) Isoxazolidine derivatives
GEP201706636B (en) Galactagogue compositions based on phosphatidylserine
WO2014064714A3 (en) Process for preparation of lurasidone hydrochloride
PT2817305T (pt) Um processo melhorado para a preparação de aprepitant
IN2013MU03768A (es)
IN2015DN02600A (es)
IN2013CH05395A (es)
IN2015KN00386A (es)
UA80618U (en) Use of n-steroylethanolamine as radiomodifier